Teribone’s Sales Growing Fast, Owing to High Demand of Drugs Promoting Bone Formation: Asahi Kasei Pharma President

Asahi Kasei Pharma President Toshio Asano said on July 17 that sales of its osteoporosis treatment Teribone (teriparatide) are rapidly increasing thanks to the growing demand of drugs that promote bone formation. Such demands “were higher than we expected,” Mr...read more